Terbutaline pump for the prevention of preterm birth
Gaudet L, Singh K, Weeks L, Skidmore B, Tsouros S, Tsertsvadze A, Daniel R, Doucette S, Walker M, Ansari MT
Record ID 32011001417
English
Authors' objectives:
To compare the benefits and harms of the SQ terbutaline pump with other tocolytics, conservative management, or placebo in specific populations of women with arrested preterm
labor, and to explore confounding by level of maternal activity and care.
Authors' recommendations:
The evidence base consists of a small number of biased studies. A substantial body of evidence originated from one proprietary database. Although evidence suggests that pump therapy is beneficial as maintenance tocolysis, our confidence in its validity and reproducibility is low. While postmarketing surveillance has detected cases of serious harms, safety of the therapy remains unclear.
Details
Project Status:
Completed
URL for project:
http://effectivehealthcare.ahrq.gov/ehc/products/157/783/CER35_Terbutaline_20110914.pdf
Year Published:
2011
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Infusion Pumps
- Obstetric Labor, Premature
- Terbutaline
- Tocolytic Agents
Contact
Organisation Name:
Agency for Healthcare Research and Quality
Contact Address:
Center for Outcomes and Evidence Technology Assessment Program, 540 Gaither Road, Rockville, MD 20850, USA. Tel: +1 301 427 1610; Fax: +1 301 427 1639;
Contact Name:
martin.erlichman@ahrq.hhs.gov
Contact Email:
martin.erlichman@ahrq.hhs.gov
Copyright:
Agency for Healthcare Research and Quality (AHRQ)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.